Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis

NCT03091439 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision outlined by the corporation.

Conditions

Osteomyelitis

Interventions

DRUG: Dalbavancin
DRUG: Standard of Care

Sponsor

Allergan